Venture

Ashkan Novin

Affiliations

University of Connecticut

Technologies

Therapeutic

Indication

Drug Discovery

Genetics & Genomics

Oncology

Personalized Medicine

Women’s health

In Genesist, we develop a CRISPR-based therapy to empower the local and healthy cells around a tumor to prevent cancer metastasis and recurrence.

Genesist Team:

Ashkan Novin